Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice
doi 10.5772/53031
Full Text
Open PDFAbstract
Available in full text
Date
February 13, 2013
Authors
Publisher
InTech